Sweden’s Natural Cycles raises €50.8M for hormone-free birth control offerings

Dr. Elina Berglund Scherwitzl, Founder of Natural Cycles. Image credit: Press photo.

Natural Cycles, the Stockholm-based Swedish startup specializing in women’s health, has obtained a substantial €50.8 million in Series C funding. The funding round was led by Lauxera Capital Partners, with participation from Point72 Private Investments and an additional revolving debt facility provided by J.P. Morgan.

The €50.8 million Series C investment it secured serves multiple purposes, including the rapid advancement of commercial growth, the fostering of groundbreaking product development, and the streamlining of healthcare reimbursement automation procedures.

Established in 2013 by Dr. Elina Berglund Scherwitzl and Dr. Raoul Scherwitzl, Natural Cycles pioneered the initial direct-to-consumer contraceptive app, boasting a three million user base globally. Notably, it stands as the sole digital contraceptive method approved by regulatory bodies in the United States (FDA), Canada (Health Canada), Europe (TÜV SÜD), Singapore (HSA), Australia (TGA), and South Korea (MFDS).

“We’ve experienced profitable growth over the last few years as women actively seek more birth control options, and we’re excited to welcome the next phase of Natural Cycles journey together with Lauxera Capital Partners and Point72 Private Investments,” stated  Dr. Raoul Scherwitzl, co-founder and CEO of the Swedish startup.

Innovative technology for hormone-free contraception

Natural Cycles demonstrates its dedication to delivering extensive hormone-free birth control options by launching NC° Postpartum, an innovative solution tailored for new mothers in their postpartum recovery phase. This latest addition to the company’s product line further solidifies its position as a pioneer in the realm of hormone-free contraceptive technologies.

The health tech firm’s innovative digital contraceptive app has regulatory clearance from various authoritative bodies, including the FDA, TÜV SÜD, Health Canada, TGA, HSA, and MFDS. It stands alone in the market as a game-changer in the field of hormone-free birth control solutions.

Speaking on behalf of Natural Cycles, Dr. Raoul Scherwitzl expressed his elation at having Lauxera Capital Partners and Point72 Private Investments join the team as they embark on the next phase of their mission to revolutionize hormone-free birth control solutions.

Techarenan News/Monok

Har du nyhetstips eller synpunkter? Kontakta oss

Skriv ut

Grunden i vår journalistik är trovärdighet och opartiskhet. Techarenan är obereoende i förhållande till politiska, religiösa, ekonomiska, offentliga och privata särintressen.